News Headline Summary

US Supreme Court accepts appeal in case involving Myriad Genetics (MYGN)

Reaction details:

- After shares fell 9.9% they have since bounced and retraced the entire downside move; trades USD 29.81 last.

Print 20:20, 30 Nov 2012 - US Equities - Source: Newswires